Jenny Rooke, a visionary investor at Genoa Ventures, is at the forefront of a transformative wave in venture capital, focusing on the powerful intersection of biology and technology. Her firm's investment thesis, which spans biotech, agtech, and industrial biotechnology, is unified under the concept of "bioconvergence"—a perspective that views biology not merely as a healthcare discipline, but as a fundamental, general-purpose technology with the potential to reshape industries, bolster national competitiveness, revolutionize agriculture, enhance human health, and unlock entirely new economic frontiers....